Author: Tina

Chronic pain affects 70 million Americans at a cost to the US economy of over $150 billion per year and the success rate for its treatment poor with treatment largely limited to opioids. Although the mechanisms underlying chronic pain are not well known, increasing evidence...

Adrenocorticotropin hormone (ACTH 1-39) is a natural endogenous protein that shows intrinsic immunomodulation via melanocortin receptors absent corticotropism. Parenteral ACTH is a FDA approved biological agent (1978) for the treatment of MS exacerbations and for flares of other autoimmune diseases for over 40 years (RA,...

This is a randomized, double-blind, parallel group, placebo-controlled study designed to evaluate the efficacy and safety of a fixed 300 mg dose of tralokinumab administered subcutaneously in subjects with uncontrolled asthma despite the use of regular asthma controller inhaled medication and having a history of asthma exacerbations.Approximately...

Age-related macular degeneration (AMD) is a disease associated with aging that gradually destroys sharp, central vision. The form of advanced AMD being studied in this clinical trial is commonly referred to as wet AMD (also called neovascular or exudative AMD). Wet AMD occurs when abnormal...

People with a retinal vein occlusion experience macular edema (swelling in the center of the retina, the thin light-sensitive tissue at the back of the eye) from blockage in a large retinal vein. This blockage is called a central retinal vein occlusion (CRVO). Retinal veins...

The purpose of this study is to use a unique eye imaging technique to compare changes in the retina in healthy volunteers to individuals with memory loss....

Researchers at the Medical College of Wisconsin are studying what kind of modifications to one’s genetic code would lead to high blood pressure. We are looking to enroll identical twins who would have same genetic code, however, with different levels of blood pressure. This would...